Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 432

1.

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

Sonnenblick A, de Azambuja E, Agbor-Tarh D, Bradbury I, Campbell C, Huang Y, Dueck AC, Pritchard KI, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Perez EA, Piccart M, Azim HA Jr.

J Natl Cancer Inst. 2016 Apr 20;108(8). pii: djw037. doi: 10.1093/jnci/djw037. Print 2016 Aug.

PMID:
27098150
2.

Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.

Norton N, Advani PP, Serie DJ, Geiger XJ, Necela BM, Axenfeld BC, Kachergus JM, Feathers RW, Carr JM, Crook JE, Moreno-Aspitia A, Anastasiadis PZ, Perez EA, Thompson EA.

PLoS One. 2016 Apr 14;11(4):e0153411. doi: 10.1371/journal.pone.0153411. eCollection 2016.

3.

Reply to C. Shah et al.

Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE.

J Clin Oncol. 2016 Mar 21. pii: JCO664714. [Epub ahead of print] No abstract available.

PMID:
27001578
4.

Pediatric liver transplantation: predictors of survival and resource utilization.

Wagenaar AE, Tashiro J, Sola JE, Ekwenna O, Tekin A, Perez EA.

Pediatr Surg Int. 2016 May;32(5):439-49. doi: 10.1007/s00383-016-3881-6. Epub 2016 Mar 21.

PMID:
27001031
5.

Blood transfusions, increased rates of surgical NEC, and lower survival: a propensity score-matched analysis.

Sayari AJ, Tashiro J, Sola JE, Perez EA.

J Pediatr Surg. 2016 Mar 3. pii: S0022-3468(16)00140-8. doi: 10.1016/j.jpedsurg.2016.02.052. [Epub ahead of print]

PMID:
26995520
6.

Hospital preference of laparoscopic versus open appendectomy: Effects on outcomes in simple and complicated appendicitis.

Tashiro J, Einstein SA, Perez EA, Bronson SN, Lasko DS, Sola JE.

J Pediatr Surg. 2016 Feb 12. pii: S0022-3468(16)00091-9. doi: 10.1016/j.jpedsurg.2016.02.028. [Epub ahead of print]

PMID:
26944182
7.

Weekday vs. weekend repair of esophageal atresia and tracheoesophageal fistula.

Sayari AJ, Tashiro J, Wang B, Perez EA, Lasko DS, Sola JE.

J Pediatr Surg. 2016 Feb 11. pii: S0022-3468(16)00077-4. doi: 10.1016/j.jpedsurg.2016.02.014. [Epub ahead of print]

PMID:
26932247
8.

Treatment strategies for advanced hormone receptor-positive and human epidermal growth factor 2-negative breast cancer: the role of treatment order.

Perez EA.

Drug Resist Updat. 2016 Jan;24:13-22. doi: 10.1016/j.drup.2015.11.001. Epub 2015 Nov 10.

PMID:
26830312
9.

Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients.

Tan WW, Allred JB, Moreno-Aspitia A, Northfelt DW, Ingle JN, Goetz MP, Perez EA.

Clin Breast Cancer. 2016 Apr;16(2):82-6. doi: 10.1016/j.clbc.2015.11.003. Epub 2015 Nov 17.

PMID:
26774555
10.

Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients.

Golpanian S, Perez EA, Tashiro J, Lew JI, Sola JE, Hogan AR.

Pediatr Surg Int. 2016 Mar;32(3):201-8. doi: 10.1007/s00383-015-3855-0. Epub 2015 Dec 30.

PMID:
26717936
11.

Surgically Treated Pediatric Nonpapillary Thyroid Carcinoma.

Golpanian S, Tashiro J, Sola JE, Allen C, Lew JI, Hogan AR, Neville HL, Perez EA.

Eur J Pediatr Surg. 2015 Dec 18. [Epub ahead of print]

PMID:
26683804
12.

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.

Piccart-Gebhart M, Holmes E, Baselga J, de Azambuja E, Dueck AC, Viale G, Zujewski JA, Goldhirsch A, Armour A, Pritchard KI, McCullough AE, Dolci S, McFadden E, Holmes AP, Tonghua L, Eidtmann H, Dinh P, Di Cosimo S, Harbeck N, Tjulandin S, Im YH, Huang CS, Diéras V, Hillman DW, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Suter T, Gelber RD, Perez EA.

J Clin Oncol. 2016 Apr 1;34(10):1034-42. doi: 10.1200/JCO.2015.62.1797. Epub 2015 Nov 23.

PMID:
26598744
13.

Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial.

Cortes J, Hudgens S, Twelves C, Perez EA, Awada A, Yelle L, McCutcheon S, Kaufman PA, Forsythe A, Velikova G.

Breast Cancer Res Treat. 2015 Dec;154(3):509-20. doi: 10.1007/s10549-015-3633-7. Epub 2015 Nov 14.

14.

Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.

Perez EA, Awada A, O'Shaughnessy J, Rugo HS, Twelves C, Im SA, Gómez-Pardo P, Schwartzberg LS, Diéras V, Yardley DA, Potter DA, Mailliez A, Moreno-Aspitia A, Ahn JS, Zhao C, Hoch U, Tagliaferri M, Hannah AL, Cortes J.

Lancet Oncol. 2015 Nov;16(15):1556-68. doi: 10.1016/S1470-2045(15)00332-0. Epub 2015 Oct 22.

PMID:
26482278
15.

Endovascular coil embolization of a pancreatic pseudoaneurysm in a child with pancreatitis.

Allen CJ, Curbelo M, Samuels SL, Perez EA, Chacon A, Gonzalez-Vallina R, Sola JE.

Pediatr Surg Int. 2015 Dec;31(12):1195-8. doi: 10.1007/s00383-015-3801-1. Epub 2015 Oct 17.

PMID:
26474572
16.

Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.

Perez EA, Ballman KV, Tenner KS, Thompson EA, Badve SS, Bailey H, Baehner FL.

JAMA Oncol. 2016 Jan 1;2(1):56-64. doi: 10.1001/jamaoncol.2015.3239.

PMID:
26469139
17.

The Globalization of Cooperative Groups.

Valdivieso M, Corn BW, Dancey JE, Wickerham DL, Horvath LE, Perez EA, Urton A, Cronin WM, Field E, Lackey E, Blanke CD.

Semin Oncol. 2015 Oct;42(5):693-712. doi: 10.1053/j.seminoncol.2015.07.003. Epub 2015 Jul 10. Review.

PMID:
26433551
18.

The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831.

Perez EA, Baehner FL, Butler SM, Thompson EA, Dueck AC, Jamshidian F, Cherbavaz D, Yoshizawa C, Shak S, Kaufman PA, Davidson NE, Gralow J, Asmann YW, Ballman KV.

Breast Cancer Res. 2015 Oct 1;17(1):133. doi: 10.1186/s13058-015-0643-7.

19.

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Perez EA, Olson JA Jr, Zujewski J, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin P, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Atkins JN, Berenberg JL, Sledge GW.

N Engl J Med. 2015 Nov 19;373(21):2005-14. doi: 10.1056/NEJMoa1510764. Epub 2015 Sep 27.

PMID:
26412349
20.

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial.

Advani PP, Ballman KV, Dockter TJ, Colon-Otero G, Perez EA.

J Clin Oncol. 2016 Feb 20;34(6):581-7. doi: 10.1200/JCO.2015.61.8413. Epub 2015 Sep 21.

PMID:
26392097
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk